Henry Schein double upgraded to Buy from Underperform at BofA
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Reuters28d
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
A full-blown board challenge would dial up ... Henry Schein senior executives exited after only a few years on the job, including Jonathan Koch, former CEO of Henry Schein's Global Dental Group ...
Nasdaq20d
Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and ...
Yahoo Finance27d
Exclusive-Activist Ananym plans to launch proxy fight at Henry Schein, sources say
NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental ... would dial up the pressure ...